Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The effects of overt hypothyroidism (HO) on cognition and mood are well established, and HO is considered a common cause of reversible dementia. There is now increasing evidence to suggest that subclinical hypothyroidism (ie, elevated thyroid stimulating hormone in the presence of normal thyroxine concentrations) may be a predisposing factor for depression, cognitive impairment, and dementia. Subclinical hypothyroidism is more common than HO and is most prevalent in the elderly, particularly in women. Older adults may be more vulnerable to the effects of subclinical hypothyroidism, given age-related changes to the hypothalamic-pituitary-thyroid axis, and there is an association between thyroid status and cognitive decline and dementia in the elderly. The purpose of this review is to summarize existing data on the cognitive and neuropsychiatric consequences of subclinical hypothyroidism, benefits of treatment, and recommendations for screening and monitoring in older adults.
- Stern RA, Prange AJ Jr: Neuropsychiatric aspects of endocrine disorders. In Comprehensive Textbook of Psychiatry, vol 6. Edited by Kaplan HI, Sadock BJ. Baltimore: Williams and Wilkins; 1995:241–251.
- Cooper DS: Subclinical hypothyroidism. N Engl J Med 2001, 345:260–265. An overview of the prevalence and medical consequences of SCH. Recommendations for screening, treatment, and an algorithm for the management of this disorder are provided. CrossRef
- Canaris GJ, Manowitz NR, Maycor G, Ridgeway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160:526–534. CrossRef
- Staub JJ, Althaus BU, Engler H, et al.: Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992, 92:631–642. CrossRef
- Sawin CT, Geller A, Wolf PA, et al.: Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 31:1249–1252. CrossRef
- Hak AE, Pols HAP, Visser TJ, et al.: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000, 132:270–278.
- Prinz PN, Scanlan JM, Vitaliano PP, et al.: Thyroid hormones positive relationships with cognition in healthy, euthyroid, older men. J Gerontol A Biol Sci Med Sci 1999, 54:M111-M116.
- Wahlin A, Wahlin TB, Small BJ, et al.: Influences of thyroid stimulating hormone on cognitive functioning in very old age. J Gerontol B Psychol Sci Soc Sci 1998, 53:234–239.
- Volpato S, Guralnik JM, Fried LP, et al.: Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 2002, 58:1055–1061. This study reported the relationship between thyroid hormone levels in the normal range and increased risk of cognitive decline over a 3-year period, and supports the notion that thyroid hormone levels may contribute to cognitive impairment and has implications for cognitive impairment in individuals with SCH.
- Ganguli M, Burmeister LA, Seaberg EC, et al.: Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 1996, 40:714–725. CrossRef
- Kvetny J: Nuclear thyroxine and triiodothyronine binding in mononuclear cells independent of age. Horm Metab Res 1985, 17:35–38.
- Mariotti S, Franceschi C, Cossarizza A, Pinchera A: The aging thyroid. Endocr Rev 1995, 16:686–715. CrossRef
- Tunbridge WMG, Evered DC, Hall R, et al.: The spectrum of thyroid disease in the community: the Whickham Survey. Clin Endocrinol 1977, 7:481–493.
- Olsen T, Laurbert P, Weeke J: Low serum triiodothyronine and high serum reverse triiodothyronine in old age: an effect of disease not age. J Clin Endocrinol Metab 1978, 47:1111–1115. CrossRef
- Evered DC, Ormston BJ, Smith PA, et al.: Grades of hypothyroidism. Br Med J 1973, 1:290–293.
- Wenzel KW, Meinhold H, Raffenberg M, et al.: Classification of hypothyroidism in evaluating patients after radioiodine therapy by serum cholesterol, T3 uptake, total T4, F-T4, Total T3, basal TSH, and TRH test. Eur J Clin Invest 1974, 4:141–148. CrossRef
- Marocchi C, Chiovato L: Thyroid-directed antibodies. In Werner and Ingbar’s the Thyroid: A Fundamental and Clinical Text, edn 8. Edited by Braverman LE, Utiger RD. Philadelphia: Lippincott Williams & Wilkins; 2000:406–415.
- Sawin CT, Chopra D, Azizi F, et al.: The aging thyroid: increased prevalence of serum thyrotropin levels in the elderly. J Am Med Assoc 1979, 242:247–250. CrossRef
- Sawin CT, Castelli WP, Hershman JM, et al.: The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985, 145:1386–1388. CrossRef
- Vanderpump MPJ, Tunbridge WMG, French JM, et al.: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995, 43:55–68.
- Hawkins BR, Dawkins RL, Burger HG, et al.: Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet 1980, 2:1057–1059. CrossRef
- Manicet G, Dartigues JF, Decamps A, et al.: The PAQUID survey and correlates of subclinical hypothyroidism in elderly community residents in the southwest of France. Age Ageing 1995, 24:235–241. CrossRef
- Sundbeck G, Eden S, Jagenburg R, et al.: Prevalence of serum antithyroid peroxidase antibodies in 85-year old women and men. Clin Chem 1995, 41:707–712.
- Pinchera A, Mariotti S, Barbesino G, et al.: Thyroid autoimmunity and aging. Horm Res 1995, 43:64–68.
- Mokshagundam S, Barzel US:Thryoid disease in the elderly. J Am Geriatr Soc 1993, 1361–1369.
- Koh LKH, Greenspan FS, Yeo PPB: Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid 1997, 7:891–896.
- Cooper DS, Halpern R, Wood LC, et al.: L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984, 101:18–24.
- Samuels MH: Subclinical thyroid disease in the elderly. Thyroid 1998, 8:803–813.
- Doucet J, Trivalle CH, Chassagne PH, et al.: Does age play a role in the clinical presentation of hypothyroidism? J Am Geriatr Soc 1994, 42:984–986.
- Baldini M, Vita A, Mauri MC, et al.: Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:925–935. CrossRef
- Monzani F, Del Guerra P, Caraccio N, et al.: Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Invest 1993, 71:367–371.
- del Ser Quijano T, Delgado C, Martinez Espinosa S, Vazquez C: Cognitive deficiency in mild hypothyroidism. Neurologia 2000, 15:193–198.
- Osterweil D, Syndulko K, Cohen SN, et al.: Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992, 40:325–335.
- Haggerty JJ, Stern RA, Mason GA, et al.: Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 1993, 150:508–510.
- Joffe RT, Levitt AJ: Major depression and subclinical hypothyroidism. Psychoendocrinology 1992, 17:215–221. CrossRef
- Tappy L, Randin J, Schwed P, et al.: Prevalence of thyroid disorders in psychogeriatric inpatients: a possible relationship of hypothyroidism with neurotic depression but not with dementia. J Am Geriatr Soc 1987, 35:526–531.
- Jackson IM: The thyroid axis and depression. Thyroid 1998, 8:951–956. CrossRef
- Esposito SM, Haggerty JJ, Stern RA, et al.: Geropsychiatric effects of subclinical hypothyroidism. Paper presented at the 147th Annual Meting of the American Psychiatric Association. Philadelphia, PA; May 1994.
- Nyström E, Caidahl K, Fager G, et al.: A double-blind crossover 12-month study of L-thyroxine treatment of women with “subclinical” hypothryoidism. Clin Endocrinol 1988, 29:63–76.
- Jaeschke R, Guyatt G, Gerstein H, et al.: Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996, 11:744–749. CrossRef
- Meier C, Staub JJ, Roth CB, et al.: TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001, 86:4860–4866. CrossRef
- Kong WM, Sheikh MH, Lumb PJ, et al.: A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidsim. Am J Med 2002, 112:348–354. CrossRef
- Trzepacz PT, McCue M, Klein I, et al.: Psychiatric and neuropsychological response to propanolol in Graves’ disease. Biol Psychiatry 1988, 23:678–688. CrossRef
- Davis JD, Stern RA: A case of apparent progressive cognitive decline in an older woman with multiple treated endocrinopathies: importance of considering endocrine status in diagnosing dementia [abstract]. J Neuropsychiatry Clin Neurosci 2003, 15:268.
- Monguilod MJM, Lopez-Fraile IP: Subclinical hypothyroidism as a cause of reversible cognitive deterioration. Neurologia 1996, 11:353–356.
- Stern RA, Robinson B, Thorner AR, et al.: A survey study of neuropsychiatric complaints in patients with Graves’ disease. J Neuropsychiatry Clin Neurosci 1996, 8:181–185.
- Stern RA, Davis JD, Rogers BL, et al.: A double-blind study of thyroxine in the treatment of Alzheimer’s dementia [abstract]. J Neuropsychiatry Clin Neurosci 2003, 15:272.
- Ladenson PW, Singer PA, Ain KB, et al.: American thyroid association guidelines of detection of thyroid dysfunction. Arch Intern Med 2000, 160:1573–1575. CrossRef
- Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly
Current Psychiatry Reports
Volume 5, Issue 5 , pp 384-390
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links